Neurovalens has developed technology that can be used to non-invasively stimulate the nervous system to treat neurological issues. The current focus is on treating the neurological elements of obesity through stimulation of the brainstem and hypothalamus.  The company has deployed  funds  from seed investment to launch a consumer weight loss product via the Indiegogo platform.  A Series A round will provide funds to scale the consumer division and conduct a larger medical device trial.